ECU
ZURA icon

Eisler Capital (US)’s Zura Bio ZURA Stock Holding History

Eisler Capital (US)’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-100,000
Closed -$40K – 690
2024
Q2 		$40K Hold
100,000
– – ﹤0.01% 603
2024
Q1 		$27K Hold
100,000
– – ﹤0.01% 509
2023
Q4 		$467K Hold
100,000
– – 0.01% 263
2023
Q3 		$660K Buy
+100,000
New +$668K 0.02% 341

Other funds holding ZURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Eisler Capital (US)'s ZURA Position: Q3 2024 in Review

Eisler Capital (US) sold out of Zura Bio (ZURA) in Q3 2024, closing a stake of 100,000 shares — an estimated $40K sold.

Eisler Capital (US) first reported a position in ZURA in Q3 2023 and held it in 4 quarters. The position peaked at $660K in Q3 2023. 78 funds tracked by Wall St. Rank hold ZURA as of Q3 2024.

  • Eisler Capital (US) reported no remaining Zura Bio position as of Q3 2024 after selling out during the quarter.
  • Eisler Capital (US) sold 100,000 Zura Bio shares in Q3 2024, an estimated $40K.
  • Eisler Capital (US) first reported a position in Zura Bio in Q3 2023 and held it in 4 quarters.
  • Eisler Capital (US)'s Zura Bio position peaked at $660K in Q3 2023.
  • 78 funds tracked by Wall St. Rank held Zura Bio as of Q3 2024.

Based on Eisler Capital (US)'s 13F filing for Q3 2024, filed 14 Nov 2024.